Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience cash
Cash and short-term investments held at the end of each period.
Zivo Bioscience's cash was $57.22K at Sep 30, 2025. For fiscal 2024 it was $1.54M, up 462.2% from the year before. Over ten years it grew 101.7% a year on average. The highest annual figure on record is $8.90M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.54M | +462.2% |
| FY2023 | Dec 31, 2023 | $274.38K | -84.8% |
| FY2022 | Dec 31, 2022 | $1.80M | -79.8% |
| FY2021 | Dec 31, 2021 | $8.90M | +6357.1% |
| FY2020 | Dec 31, 2020 | $137.86K | -60.2% |
| FY2019 | Dec 31, 2019 | $346.11K | -11.0% |
| FY2018 | Dec 31, 2018 | $388.89K | +22.6% |
| FY2017 | Dec 31, 2017 | $317.14K | -37.4% |
| FY2016 | Dec 31, 2016 | $506.99K | +2956.2% |
| FY2015 | Dec 31, 2015 | $16.59K | +1099.5% |
| FY2014 | Dec 31, 2014 | $1.38K | -99.7% |
| FY2013 | Dec 31, 2013 | $493.10K | +945.9% |
| FY2012 | Dec 31, 2012 | $47.15K | -79.1% |
| FY2011 | Dec 31, 2011 | $225.70K | +1346.5% |
| FY2010 | Dec 31, 2010 | $15.60K | – |
| FY2009 | Dec 31, 2009 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $57.22K | -64.1% |
| Q2 FY2025 | Jun 30, 2025 | $9.82K | +298.3% |
| Q1 FY2025 | Mar 31, 2025 | $517.19K | +273.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.54M | +462.2% |
| Q3 FY2024 | Sep 30, 2024 | $159.40K | -89.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.47K | -88.3% |
| Q1 FY2024 | Mar 31, 2024 | $138.64K | -33.5% |
| Q4 FY2023 | Dec 31, 2023 | $274.38K | -84.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.48M | -56.2% |
| Q2 FY2023 | Jun 30, 2023 | $21.07K | -99.6% |
| Q1 FY2023 | Mar 31, 2023 | $208.60K | -96.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.80M | -79.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.39M | -68.7% |
| Q2 FY2022 | Jun 30, 2022 | $5.08M | -53.4% |
| Q1 FY2022 | Mar 31, 2022 | $6.60M | +2745.2% |
| Q4 FY2021 | Dec 31, 2021 | $8.90M | +6357.1% |
| Q3 FY2021 | Sep 30, 2021 | $10.80M | +19412.0% |
| Q2 FY2021 | Jun 30, 2021 | $10.90M | +9072.5% |
| Q1 FY2021 | Mar 31, 2021 | $231.94K | +2209.4% |
| Q4 FY2020 | Dec 31, 2020 | $137.86K | -60.2% |
| Q3 FY2020 | Sep 30, 2020 | $55.37K | +258.9% |
| Q2 FY2020 | Jun 30, 2020 | $118.87K | +173.0% |
| Q1 FY2020 | Mar 31, 2020 | $10.04K | +134.4% |
| Q4 FY2019 | Dec 31, 2019 | $346.11K | -11.0% |
| Q3 FY2019 | Sep 30, 2019 | $15.43K | -93.2% |
| Q2 FY2019 | Jun 30, 2019 | $43.53K | -93.6% |
| Q1 FY2019 | Mar 31, 2019 | $4.29K | -95.6% |
| Q4 FY2018 | Dec 31, 2018 | $388.89K | +22.6% |
| Q3 FY2018 | Sep 30, 2018 | $228.39K | -81.3% |
| Q2 FY2018 | Jun 30, 2018 | $677.99K | +2700.7% |
| Q1 FY2018 | Mar 31, 2018 | $98.14K | -90.3% |
| Q4 FY2017 | Dec 31, 2017 | $317.14K | -37.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.22M | +109.2% |
| Q2 FY2017 | Jun 30, 2017 | $24.21K | -5.9% |
| Q1 FY2017 | Mar 31, 2017 | $1.01M | +288.7% |
| Q4 FY2016 | Dec 31, 2016 | $506.99K | +2956.2% |
| Q3 FY2016 | Sep 30, 2016 | $585.28K | – |
| Q2 FY2016 | Jun 30, 2016 | $25.73K | – |
| Q1 FY2016 | Mar 31, 2016 | $259.23K | – |
| Q4 FY2015 | Dec 31, 2015 | $16.59K | – |
See a number that looks wrong?